Inventor · disambiguated record
Lieping Chen
Also filed as: CHEN LIEPING
53 granted patents·46 pending applications·1,637 citations·filing 1995–2025
99Inventor score
Files withMAYO FOUNDATION28CHEN LIEPING18UNIV JOHNS HOPKINS11MAYO FOUND MEDICAL EDUCATION & RES9UNIV YALE9
Top patents by PatentIndex Score
99 records- 0199US8981063B2B7-H1 AntibodiesCHEN LIEPING·Filed 2009·Granted Mar 17, 2015·91 cites·27 claims
- 0299US8460927B2B7-H1 antibodies and method of useCHEN LIEPING·Filed 2011·Granted Jun 11, 2013·125 cites·6 claims
- 0398US7892540B2B7-H1 and methods of diagnosis, prognosis, and treatment of cancerMAYO FOUNDATION·Filed 2005·Granted Feb 22, 2011·84 cites·22 claims
- 0498US7794710B2Methods of enhancing T cell responsivenessMAYO FOUNDATION·Filed 2002·Granted Sep 14, 2010·165 cites·20 claims
- 0598US7432351B1B7-H1 variantsMAYO FOUNDATION·Filed 2003·Granted Oct 7, 2008·81 cites·27 claims
- 0698US6891030B2T-cell immunoregulatory moleculeMAYO FOUNDATION·Filed 2001·Granted May 10, 2005·107 cites·2 claims
- 0797US8772026B2Enhancement of immune responses by 4-1 BB-binding agentsCHEN LIEPING·Filed 2012·Granted Jul 8, 2014·26 cites·18 claims
- 0897US8445447B2B7-DC variants immunogenic compositions and methods of use thereofCHEN LIEPING·Filed 2012·Granted May 21, 2013·23 cites·25 claims
- 0997US8153595B2B7-DC variants immunogenic compositions and methods of use thereofCHEN LIEPING·Filed 2008·Granted Apr 10, 2012·46 cites·53 claims
- 1097US7919585B2B7-H5, a costimulatory polypeptideMAYO FOUNDATION·Filed 2005·Granted Apr 5, 2011·36 cites·25 claims
- 1196US8840889B2Methods of modulating immune functionCHEN LIEPING·Filed 2010·Granted Sep 23, 2014·33 cites·7 claims
- 1296US8039589B1B7-DC variantsMAYO FOUNDATION·Filed 2007·Granted Oct 18, 2011·24 cites·57 claims
- 1396US7931896B2Compositions and methods for treating inflammation and auto-immune diseasesUNIV JOHNS HOPKINS·Filed 2007·Granted Apr 26, 2011·32 cites·16 claims
- 1496US7875702B2B7-H3 and B7-H4, novel immunoregulatory moleculesMAYO FOUNDATION·Filed 2007·Granted Jan 25, 2011·22 cites·17 claims
- 1596US7622565B2Nucleic acids encoding B7-H4, a T cell immunoregulatory moleculeMAYO FOUNDATION·Filed 2005·Granted Nov 24, 2009·24 cites·15 claims
- 1696US6803192B1B7-H1, a novel immunoregulatory moleculeMAYO FOUNDATION·Filed 1999·Granted Oct 12, 2004·173 cites·13 claims
- 1795US9574000B2Anti-human B7-H4 antibodies and their usesMEDIMMUNE LLC·Filed 2013·Granted Feb 21, 2017·62 cites·15 claims
- 1895US9062112B2B7-H1, a novel immunoregulatory moleculeCHEN LIEPING·Filed 2008·Granted Jun 23, 2015·17 cites·84 claims
- 1995US8747833B2B7-H1 and methods of diagnosis, prognosis, and treatment of cancerCHEN LIEPING·Filed 2011·Granted Jun 10, 2014·23 cites·3 claims
- 2095US8273864B2Nucleic acid molecules encoding B7-DC variantsCHEN LIEPING·Filed 2011·Granted Sep 25, 2012·15 cites·61 claims
- 2195US7651686B2Enhancement of immune responses by 4-1bb-binding agentsMAYO FOUNDATION·Filed 2002·Granted Jan 26, 2010·46 cites·28 claims
- 2294US8129347B2Methods for treating autoimmune diseases using B7-H4 polypeptides and fragments thereofCHEN LIEPING·Filed 2007·Granted Mar 6, 2012·17 cites·64 claims
- 2394US7847081B2Nucleic acids encoding B7-H4, a T cell immunoregulatory moleculeMAYO FOUNDATION·Filed 2007·Granted Dec 7, 2010·16 cites·24 claims
- 2494US6210669B1Methods and compositions for immunomodulationBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Apr 3, 2001·194 cites·9 claims
- 2593US9803015B2Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUNDATION·Filed 2016·Granted Oct 31, 2017·8 cites·7 claims
- 2693US8236767B2Methods for treating inflammation using B7-H4 polypeptides and fragments thereofCHEN LIEPING·Filed 2011·Granted Aug 7, 2012·11 cites·49 claims
- 2793US8163550B2Enhancement of immune responses by 4-1BB-binding agentsCHEN LIEPING·Filed 2009·Granted Apr 24, 2012·21 cites·19 claims
- 2893US7449300B2Detection of antibodies specific for B7-H1 in subjects with diseases or pathological conditions mediated by activated T cellsMAYO FOUNDATION·Filed 2003·Granted Nov 11, 2008·44 cites·11 claims
- 2991US2024352120A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2024·Application pending·0 cites
- 3090US8703916B2B7-H3 and B7-H4, novel immunoregulatory moleculesCHEN LIEPING·Filed 2012·Granted Apr 22, 2014·7 cites·11 claims
- 3190US7989173B2Detection and diagnosis of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2008·Granted Aug 2, 2011·11 cites·36 claims
- 3288US9555124B2B7-H3 and B7-H4, novel immunoregulatory moleculesMAYO FOUNDATION·Filed 2014·Granted Jan 31, 2017·5 cites·41 claims
- 3387US11987629B2Compositions and uses thereof for treating disease or conditionTAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD·Filed 2019·Granted May 21, 2024·3 cites·20 claims
- 3486US10465007B2Anti-PD-1 antibodies and uses thereofTAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD·Filed 2019·Granted Nov 5, 2019·5 cites·11 claims
- 3585US8440185B2Compositions and methods for the treatment of immunologic disordersCHEN LIEPING·Filed 2007·Granted May 14, 2013·5 cites·11 claims
- 3681US11939378B2Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Granted Mar 26, 2024·0 cites·3 claims
- 3780US10501520B2B7-H5, a costimulatory polypeptideMAYO FOUND MEDICAL EDUCATION & RES·Filed 2017·Granted Dec 10, 2019·1 cites·13 claims
- 3879US11560430B2Anti-PD-1 antibodies and uses thereofTAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD·Filed 2019·Granted Jan 24, 2023·1 cites·17 claims
- 3979US11242387B2Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Feb 8, 2022·0 cites·1 claims
- 4079US9012409B2B7-H5, a costimulatory polypeptideMAYO FOUNDATION·Filed 2013·Granted Apr 21, 2015·2 cites·24 claims
- 4179US8426563B2Antibody specific for B7-H5, a costimulatory polypeptideCHEN LIEPING·Filed 2011·Granted Apr 23, 2013·2 cites·16 claims
- 4278US10316092B2Anti-B7-H5 antibodies and their usesMEDIMMUNE LLC·Filed 2014·Granted Jun 11, 2019·3 cites·12 claims
- 4378US9676856B2Methods of modulating immune functionUNIV JOHNS HOPKINS·Filed 2014·Granted Jun 13, 2017·2 cites·18 claims
- 4477US2024182579A1Anti-pd-1 antibodies and uses thereofTAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 4576US11760787B2B7-H5, a costimulatory polypeptideMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Sep 19, 2023·0 cites·13 claims
- 4675US9884903B2B7-H5, a costimulatory polypeptideMAYO FOUND MEDICAL EDUCATION & RES·Filed 2015·Granted Feb 6, 2018·1 cites·19 claims
- 4775US2025352598A1Improved Therapeutic Index of Anti-Immune Checkpoint Inhibitors Using Combination Therapy Comprising A PHY906 Extract, A Scutellaria baicalensis Georgi (S) Extract or A Compound From Such ExtractsUNIV YALE·Filed 2025·Application pending·0 cites
- 4870US2013330329A1B7-h7 antibodies and method of useMAYO FOUNDATION·Filed 2013·Application pending·0 cites
- 4968US2022168419A1Compositions and methods for treating autoimmune diseases and cancersUNIV YALE·Filed 2022·Application pending·0 cites
- 5068US2018179281A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2018·Application pending·0 cites
Showing the top 50 of 99 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →